Has Stephen Peirce, MD received payments from drug or device companies?

Yes. Drug and device makers reported $27,526 in general payments to Stephen Peirce, MD across 334 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Peirce, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Peirce, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Peirce, MD

Interventional Pain Medicine · Eugene, ORNPI 1558898528

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 27.0% of the total. 2025 is the largest year on record at $9,200, 6.0 times the $1,536 reported in 2021. Among interventional pain medicine clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,526in general payments, 2019–2025

Across 334 payments — averaging $82.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$7K
Foundation Fusion Solutions, LLC$7K
Boston Scientific$4K
Abbott$4K
Nalu Medical, Inc.$2K
MML US, Inc.$1K
plus $2K from 15 others

What the payments were for

Consulting fees$6,70024%
Travel & lodging$11,30841%
Food & beverage$9,48634%
Education$170%
Entertainment$150%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	155	$7,418
Foundation Fusion Solutions, LLC	13	$7,017
Boston Scientific	56	$4,390
Abbott	23	$3,857
Nalu Medical, Inc.	34	$1,501
MML US, Inc.	15	$1,434
Trice Medical, Inc.	3	$646
Painteq LLC	8	$373
Relievant Medsystems, Inc.	6	$193
Vertos Medical, Inc.	2	$148
Biotronik NRO, Inc.	3	$89
Stryker	1	$73
SPR Therapeutics, Inc	1	$65
Curonix LLC	4	$62
Spinefrontier, Inc.	1	$59
Spinal Simplicity, LLC	2	$56
Saluda Medical Americas, Inc.	1	$50
Vertex	2	$36
AbbVie	1	$25
Merit Medical Systems Inc	2	$17
Nevro Corp.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PRODIGY$1,719
Superion Indirect Decompression System$1,536
INTELLIS ADAPTIVESTIM$1,410
ReActiv8$1,196
KYPHON EXPRESS II KYPHOPAK TRAY$1,160
PROCLAIM$1,121
Nalu Neurostimulation System$948
VANTA ADAPTIVESTIM$926
SYNCHROMEDII$806
Proclaim IPG$789
SPECTRA WAVEWRITER$236
Intracept$132
PAINTEQ$109
GENERAL PAIN MANAGEMENT$104
OSTEOCOOL RF ABLATION SYSTEM$102

How this compares

$27,526 in reported general payments places this provider in the 90th percentile of 22 interventional pain medicine providers in Oregon.

See all interventional pain medicine providers in Oregon →

Medicare billing

Part B allowed, 2024

$170,406

Medicare patients

295

Services billed

5,736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxymorphone Hcl ErOxymorphone Hcl	11	$3,282
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	129	$1,897
Gabapentin	91	$1,039
Oxycodone Hcl	80	$1,035
Methadone Hcl	21	$392
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	11	$339
Duloxetine Hcl	19	$238
Celecoxib	13	$223
Pregabalin	25	$221
Cyclobenzaprine Hcl	36	$122
Meloxicam	40	$102
Nortriptyline Hcl	14	$66
Tramadol Hcl	18	$65
Alprazolam	34	$27

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Eugene

Gregory MooreEugene$377K
Gregory PhillipsEugene$50K
Rishi VoraEugene$16K
Joseph DunnEugene$10K
Donna MorganEugene$9K
George JohnstonMedford$14K
Poly ChenSalem$14K
Kwo Wei HoTigard$13K
Carl BalogPortland$12K
Vladimir FiksPortland$8K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →